Lever Bio aims to translate groundbreaking discoveries in immuno-oncology into next-generation cancer immunotherapies.
Total raised: $4.53M
Funding Rounds 1
| Date | Series | Amount | Investors |
| 28.05.2025 | - | $4.53M | - |
Mentions in press and media 2
| Date | Title | Description |
| 28.05.2025 | Lever Bio Raises €4M in Funding | Lever Bio, a Turin, Italy-based immuno-oncology company, raised €4M in funding. The round was led by Claris Ventures. The company intends to use the funds to further progress the assets through preclinical development and validate their the... |
| - | Lever Bio | “Lever Bio aims to translate groundbreaking discoveries in immuno-oncology into next-generation cancer immunotherapies.” |